3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
57
Leukemia, Lymphocytic, Chronic, B-Cell
30
Myelodysplastic Syndromes
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Leukemia, Myelomonocytic, Chronic
15
Myeloproliferative Disorders
12
Lymphoma
12
Leukemia, Biphenotypic, Acute
11
Burkitt Lymphoma
11
Lymphoma, Follicular
9
Leukemia
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Myelodysplastic-Myeloproliferative Diseases
8
Hematologic Neoplasms
8
Lymphoma, Mantle-Cell
7
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, B-Cell, Marginal Zone
7
Multiple Myeloma
6
Lymphoma, Non-Hodgkin
6
Leukemia, Monocytic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Lymphoma, T-Cell, Cutaneous
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Congenital Abnormalities
4
Lymphoma, T-Cell
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, B-Cell
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Hairy Cell
3
Interventions
Melphalan
4
fludarabine
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Cyclophosphamide
2
Busulfan
2
Bone Marrow Transplantation
2
Alemtuzumab
2
venetoclax
1
spartalizumab
1
sabatolimab
1
ruxolitinib
1
lintuzumab
1
filanesib
1
Stem Cell Transplantation
1
Sertraline
1
Sampling Studies
1
Metformin
1
Lenalidomide
1
Decitabine
1
Clofarabine
1
CPI-0610
1
Biopsy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Preleukemia
×
Biopsy
×
Other hematologic neoplasm
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled